Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RNAZRNAZ
2 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TRANSCODE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC previously held 0 shares of RNAZ (TRANSCODE THERAPEUTICS INC), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$218,728

Total Shares Change

-28,042

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$10.65
0
2025-Q2
New
28,042
-
$218,7280.0%$7.97
35

Other major holders of RNAZ: GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used